James Mulay
CIK: 0001684531
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CG Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Jul 10, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct24.2K shares at avg. $26.63$644K - Jul 10, 2026CGON
CG Oncology, Inc.
Sale(S)Direct24.2K shares at avg. $75.16$1.8M - Jun 15, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct1.3K shares at avg. $12.59$16K - Jun 15, 2026CGON
CG Oncology, Inc.
Sale(S)Direct1.3K shares at avg. $60.12$79K - Jun 15, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct654 shares at avg. $3.72$2K - Jun 15, 2026CGON
CG Oncology, Inc.
Sale(S)Direct654 shares at avg. $60.12$39K - Jun 4, 2026CGON
CG Oncology, Inc.
Award(A)DirectDirector Stock Option (right to buy)
9.4K shares- - Apr 17, 2026CGON
CG Oncology, Inc.
Sale(S)Direct15.6K shares at avg. $73.01$1.1M - Apr 17, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct15.6K shares at avg. $36.63$571K - Mar 16, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct1.3K shares at avg. $12.59$16K - Mar 16, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct654 shares at avg. $3.72$2K - Mar 16, 2026CGON
CG Oncology, Inc.
Sale(S)Direct654 shares at avg. $63.50$42K - Mar 16, 2026CGON
CG Oncology, Inc.
Sale(S)Direct1.3K shares at avg. $63.50$83K - Jan 9, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct10.5K shares at avg. $12.59$132K - Jan 9, 2026CGON
CG Oncology, Inc.
Sale(S)Direct10.5K shares at avg. $52.99$556K - Jan 9, 2026CGON
CG Oncology, Inc.
Sale(S)Direct654 shares at avg. $44.16$29K - Jan 9, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct654 shares at avg. $3.72$2K - Oct 9, 2025CGON
CG Oncology, Inc.
Sale(S)Direct5.9K shares at avg. $43.99$260K - Oct 9, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct5.9K shares at avg. $3.72$22K - Sep 29, 2025CGON
CG Oncology, Inc.
Sale(S)Direct12.8K shares at avg. $39.19$500K - Sep 29, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct12.8K shares at avg. $1.82$23K - Sep 19, 2025CGON
CG Oncology, Inc.
Sale(S)Direct3.6K shares at avg. $38.99$139K - Sep 19, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct3.6K shares at avg. $1.82$7K - Sep 18, 2025CGON
CG Oncology, Inc.
Sale(S)Direct19.1K shares at avg. $39.01$746K - Sep 18, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct19.1K shares at avg. $1.82$35K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 24,165 | $26.63 | $643,514 | Direct |
| Jul 10, 2026 | CGON CG Oncology, Inc. | Sale(S) | 24,165 | $75.16 | $1,816,241 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 1,310 | $12.59 | $16,493 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Sale(S) | 1,310 | $60.12 | $78,757 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 654 | $3.72 | $2,433 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Sale(S) | 654 | $60.12 | $39,318 | Direct |
| Jun 4, 2026 | CGON CG Oncology, Inc. | Award(A) Director Stock Option (right to buy) | 9,354 | - | - | Direct |
| Apr 17, 2026 | CGON CG Oncology, Inc. | Sale(S) | 15,600 | $73.01 | $1,138,956 | Direct |
| Apr 17, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 15,600 | $36.63 | $571,428 | Direct |
| Mar 16, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 1,310 | $12.59 | $16,493 | Direct |
| Mar 16, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 654 | $3.72 | $2,433 | Direct |
| Mar 16, 2026 | CGON CG Oncology, Inc. | Sale(S) | 654 | $63.50 | $41,529 | Direct |
| Mar 16, 2026 | CGON CG Oncology, Inc. | Sale(S) | 1,310 | $63.50 | $83,185 | Direct |
| Jan 9, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 10,491 | $12.59 | $132,082 | Direct |
| Jan 9, 2026 | CGON CG Oncology, Inc. | Sale(S) | 10,491 | $52.99 | $555,918 | Direct |
| Jan 9, 2026 | CGON CG Oncology, Inc. | Sale(S) | 654 | $44.16 | $28,881 | Direct |
| Jan 9, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 654 | $3.72 | $2,433 | Direct |
| Oct 9, 2025 | CGON CG Oncology, Inc. | Sale(S) | 5,903 | $43.99 | $259,673 | Direct |
| Oct 9, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 5,903 | $3.72 | $21,959 | Direct |
| Sep 29, 2025 | CGON CG Oncology, Inc. | Sale(S) | 12,755 | $39.19 | $499,868 | Direct |
| Sep 29, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 12,755 | $1.82 | $23,214 | Direct |
| Sep 19, 2025 | CGON CG Oncology, Inc. | Sale(S) | 3,574 | $38.99 | $139,350 | Direct |
| Sep 19, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 3,574 | $1.82 | $6,505 | Direct |
| Sep 18, 2025 | CGON CG Oncology, Inc. | Sale(S) | 19,112 | $39.01 | $745,559 | Direct |
| Sep 18, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 19,112 | $1.82 | $34,784 | Direct |
1-25 of 32 transactions
About Mulay James
Mulay James (SEC CIK 0001684531) files insider reports with the SEC as Director of CG Oncology, Inc. (CGON).
Signal8 holds 12 ownership filings by Mulay James, all Form 4s, filed between Oct 7, 2024 and Jul 14, 2026. Those filings report 32 transactions, from Oct 4, 2024 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mulay James's filings is in DALLAS, TX.
Recent filings by Mulay James
- Jul 10, 2026: Option exercise of CGON shares (Form 4, code M).
- Jul 10, 2026: Open-market sale of CGON shares (Form 4, code S).
- Jun 15, 2026: Option exercise of CGON shares (Form 4, code M).
- Jun 15, 2026: Open-market sale of CGON shares (Form 4, code S).
- Jun 15, 2026: Option exercise of CGON shares (Form 4, code M).
Other insiders filing for CG Oncology, Inc. (CGON)
- Kalofonos Isabel, Chief Commercial Officer
- POST LEONARD E, Director
- Liu Brian Guan-Chyun, Director
- Tong Victor Edward Jr, Director
- Rossi Christina, Director
- Graf Susan E, Director